Astria Therapeutics Inc (ATXS) Live Share Price, Invest From India

Astria Therapeutics Inc Stock Performance

as on January 23, 2026 at 2:29 am IST

Day's Low
Day's High
$12.45
Day's Price Range
$12.59
$12.55
0.80%
Downside
0.32%
Upside
52 Week's Low
52 Week's High
$3.56
52-Week Price Range
$13.29
$12.55
71.67%
Downside
5.90%
Upside

Astria Therapeutics Inc share price movements today

Previous Close: $12.50
Open: $12.48
Volume: 2.2M
Day's Low - High: $12.45 - $12.59
52 Week Low - High: $3.56 - $13.29

Astria Therapeutics Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Astria Therapeutics Inc Stock Fundamentals & Key Indicators

Check Astria Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Astria Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Astria Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Astria Therapeutics Inc	BUY	$-	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$47.7B	100.62%	1246.03	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$122.3B	113.14%	33.56	31.35%
Beone Medicines Ltd	NA	$37.4B	NA	662.33	1.38%
Regeneron Pharmaceuticals, Inc.	BUY	$80.8B	53.64%	18.28	32.13%

Analyst Recommendation on Astria Therapeutics Inc Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Astria Therapeutics Inc. Average target price of $24.6

Astria Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Astria Therapeutics Inc.

What analysts predicted

48.98%UPSIDE

Target Price

$24.6

Current Price

$12.55

Analyzed by

13 Analysts

Target

$24.60

Astria Therapeutics Inc target price $24.6, a slight upside of 48.98% compared to current price of $12.55. According to 13 analysts rating.

Astria Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	-	-	-	-	-	-	-	0
Gross Profit	-	-	-	-	-	-	-	-	-	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-12	-17	-31	-19	-24	-24	-25	-33	-33	-31
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-4482.01%

Astria Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	-	-	-	-	-	-	-
Gross Profit	0	0	0	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	-27	-25	-26	-37	-194	-50	-72	-94
Net Profit Margin	-5472.80%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Global Institutional Holdings in Astria Therapeutics Inc

Funds	Holdings
State Street Corp	1.66%
FCPM III SERVICES BV	7.28%
Millennium Management LLC	5.26%
Geode Capital Management, LLC	1.71%
TCG Crossover Management, LLC	4.89%

See all

Insights on Astria Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ATXS has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 6 months, ATXS stock has moved up by 89.2%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 29.7% return, outperforming this stock by 39.8%

About Astria Therapeutics Inc

Astria Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for allergic and immunological diseases. Its lead product candidate is Navenibart, a potential monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema (HAE), a rare, autosomal dominant genetic disorder. Its second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in clinical development for the treatment of atopic dermatitis (AD), an immune disorder associated with loss of skin barrier function and itching. It owns five patent families directed to navenibart. The first patent family is directed to the composition of matter of navenibart and its use in treating various plasma kallikrein associated disorders, including HAE. In the second patent family, it is directed to methods of treating various plasma-kallikrein-associated disorders, including HAE.

Organisation	Astria Therapeutics Inc
E-voting on shares	Click here to vote

FAQs

What is Astria Therapeutics Inc share price today?

Astria Therapeutics Inc share price today is $12.55 as on January 23, 2026 at 2:29 am IST at the close of the market. Astria Therapeutics Inc share today touched a day high of $12.59 and a low of $12.45.

What is the 52 week high and 52 week low for Astria Therapeutics Inc share?

Astria Therapeutics Inc share touched a 52 week high of $13.29 on December 4, 2025 and a 52 week low of $3.56 on April 9, 2025. Astria Therapeutics Inc stock price today i.e. January 23, 2026 at 2:29 am IST is closed at $12.55,which is 5.57% down from its 52 week high and 253.02% up from its 52 week low.

How to invest in Astria Therapeutics Inc Stock (ATXS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Astria Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Astria Therapeutics Inc Shares that will get you 0.1195 shares as per Astria Therapeutics Inc share price of $12.55 per share as on January 23, 2026 at 2:29 am IST.

What is the minimum amount required to buy Astria Therapeutics Inc Stock (ATXS) from India?

Indian investors can start investing in Astria Therapeutics Inc (ATXS) shares with as little as ₹90.283 or $1 (as of February 6, 2026 at 1:31 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹902.83 in Astria Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on February 6, 2026 at 1:31 pm IST). Based on Astria Therapeutics Inc share’s latest price of $12.55 as on January 23, 2026 at 2:29 am IST, you will get 0.7968 shares of Astria Therapeutics Inc. Learn more about fractional shares .